Perfil
Michelle Gates is currently Chief People Officer at CAMP4 Therapeutics Corp.
since 2021.
Formerly, Ms. Gates was Vice President-Human Resources at Akamai Technologies, Inc. from 2005 to 2021, Human Resources Manager at Teradyne, Inc. from 2004 to 2005, and Human Resources Director at British Telecommunications Ltd. from 2001 to 2004.
Ms. Gates completed undergraduate education at Providence College.
Cargos activos de Michelle Gates
| Empresas | Cargo | Inicio |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Oficial de Recursos Humanos | 01/06/2021 |
Antiguos cargos conocidos de Michelle Gates.
| Empresas | Cargo | Fin |
|---|---|---|
| AKAMAI TECHNOLOGIES, INC. | Oficial de Recursos Humanos | 01/06/2021 |
| TERADYNE, INC. | Oficial de Recursos Humanos | 01/01/2005 |
British Telecommunications Plc
British Telecommunications Plc Major TelecommunicationsCommunications Provides telecommunication services | Oficial de Recursos Humanos | 01/01/2004 |
Formación de Michelle Gates.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Teradyne, Inc.
Teradyne, Inc. Electronic Production EquipmentElectronic Technology Designs, manufactures, markets and services electronic test systems | Electronic Technology |
Akamai Technologies, Inc.
Akamai Technologies, Inc. Data Processing ServicesTechnology Services Provides cloud computing, security and content delivery services | Technology Services |
British Telecommunications Plc
British Telecommunications Plc Major TelecommunicationsCommunications Provides telecommunication services | Communications |
Providence College
Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Michelle Gates
















